Christopher L. Corless

Q: What Schools Are Affiliated With Christopher L. Corless

Christopher L. Corless is affiliated with the following schools: University of British Columbia, University of Southern California, Oregon Health & Science University, Massachusetts General Hospital, Duke University, Peking University, University of Helsinki

Christopher L. Corless's AcademicInfluence.com Rankings

Philosophy

#6065

World Rank

#9033

Historical Rank

Logic

#3259

World Rank

#4389

Historical Rank

philosophy Degrees

Christopher L. Corless

Biology

#8217

World Rank

#11259

Historical Rank

Pathology

#105

World Rank

#216

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Christopher L. Corless's Degrees

Doctorate Medicine University of Utah
PhD Pathology University of Utah

Why Is Christopher L. Corless Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Christopher L. Corless's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. (2002) (4091)
Diagnosis of gastrointestinal stromal tumors: A consensus approach. (2002) (3533)
PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors (2003) (2321)
Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. (2003) (2202)
Biology of gastrointestinal stromal tumors. (2004) (1155)
Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT. (2008) (931)
PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib. (2005) (815)
Molecular correlates of imatinib resistance in gastrointestinal stromal tumors. (2006) (763)
Gastrointestinal stromal tumours: origin and molecular oncology (2011) (733)
Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor. (2008) (662)
Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies. (2002) (652)
The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. (2004) (626)
NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines. (2007) (623)
Gastrointestinal stromal tumour (2013) (619)
Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification. (2011) (616)
KIT Gene Mutations and Copy Number in Melanoma Subtypes (2008) (600)
Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205. (2010) (579)
Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group. (2008) (559)
Gastrointestinal stromal tumour (2007) (547)
KIT-Negative Gastrointestinal Stromal Tumors: Proof of Concept and Therapeutic Implications (2004) (502)
Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin. (2013) (462)
KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size. (2002) (434)
Major response to imatinib mesylate in KIT-mutated melanoma. (2008) (431)
Guidelines for Validation of Next-Generation Sequencing-Based Oncology Panels: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists. (2017) (430)
Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225. (2005) (427)
Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. (1995) (427)
A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. (2006) (412)
A Novel Monoclonal Antibody Against DOG1 is a Sensitive and Specific Marker for Gastrointestinal Stromal Tumors (2008) (387)
Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. (2000) (348)
Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases. (1997) (330)
KIT mutations are common in testicular seminomas. (2004) (322)
Molecular pathobiology of gastrointestinal stromal sarcomas. (2008) (319)
Vascular and nonvascular expression of INCAM-110. A target for mononuclear leukocyte adhesion in normal and inflamed human tissues. (1991) (317)
Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor). (2006) (301)
TLE1 as a Diagnostic Immunohistochemical Marker for Synovial Sarcoma Emerging From Gene Expression Profiling Studies (2007) (299)
SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma. (2015) (264)
Monoclonal Antibody DOG1.1 Shows Higher Sensitivity Than KIT in the Diagnosis of Gastrointestinal Stromal Tumors, Including Unusual Subtypes (2009) (257)
Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial. (2014) (252)
Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis. (2005) (238)
MicroRNA expression signature of human sarcomas (2008) (230)
The metabolic syndrome resulting from a knockout of the NEIL1 DNA glycosylase. (2006) (227)
Efficacy and safety of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of imatinib and sunitinib: a multicenter phase II trial. (2012) (223)
Resistance to Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors (2009) (211)
High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. (1995) (209)
Large-Scale Analysis of KIT Aberrations in Chinese Patients with Melanoma (2011) (209)
Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma. (2006) (207)
Papillary Renal Cell Carcinoma: Quantitation of Chromosomes 7 and 17 by FISH, Analysis of Chromosome 3p for LOH, and DNA Ploidy (1996) (207)
Absence of BRAF and NRAS mutations in uveal melanoma. (2003) (206)
Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial. (2015) (203)
Determination of Stromal Signatures in Breast Carcinoma (2005) (201)
The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas (2004) (197)
Overexpression of Transforming Growth Factor β1 in Head and Neck Epithelia Results in Inflammation, Angiogenesis, and Epithelial Hyperproliferation (2004) (197)
Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis. (1996) (192)
NCCN Task Force report: optimal management of patients with gastrointestinal stromal tumor (GIST)--expansion and update of NCCN clinical practice guidelines. (2004) (188)
Clinicopathologic profile of gastrointestinal stromal tumors (GISTs) with primary KIT exon 13 or exon 17 mutations: a multicenter study on 54 cases (2008) (177)
Phase II, Open-Label Study Evaluating the Activity of Imatinib in Treating Life-Threatening Malignancies Known to Be Associated with Imatinib-Sensitive Tyrosine Kinases (2008) (177)
E-selectin is present in proliferating endothelial cells in human hemangiomas. (1996) (165)
Diagnosis of Gastrointestinal Stromal Tumors:A Consensus Approach (2002) (165)
High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. (2003) (160)
Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation. (1998) (158)
Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors. (2007) (158)
Gastrointestinal stromal tumors: what do we know now? (2014) (153)
FGFR1 and NTRK3 actionable alterations in “Wild-Type” gastrointestinal stromal tumors (2016) (150)
Cytomegalovirus viremia: risk factor for allograft cirrhosis after liver transplantation for hepatitis C. (1997) (148)
Small (< or = 3 cm) renal masses: correlation of spiral CT features and pathologic findings. (1994) (147)
Transplanted human bone marrow contributes to vascular endothelium. (2004) (145)
Long-term Results of Adjuvant Imatinib Mesylate in Localized, High-Risk, Primary Gastrointestinal Stromal Tumor: ACOSOG Z9000 (Alliance) Intergroup Phase 2 Trial (2013) (143)
Gastrointestinal stromal tumors (GISTs) with KIT and PDGFRA mutations have distinct gene expression profiles (2004) (139)
Expression of cell cycle-regulated proteins in prostate cancer. (1996) (138)
Gastrointestinal stromal tumours: consensus statement on diagnosis and treatment. (2006) (135)
Hypoxia-induced inflammatory cytokine secretion in human adipose tissue stromovascular cells (2011) (135)
Gastric GI stromal tumors (GISTs): The role of surgery in the era of targeted therapy (2005) (130)
Molecular Target Modulation, Imaging, and Clinical Evaluation of Gastrointestinal Stromal Tumor Patients Treated with Sunitinib Malate after Imatinib Failure (2009) (126)
Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma (2010) (125)
Combining highly multiplexed PCR with semiconductor-based sequencing for rapid cancer genotyping. (2013) (125)
Imatinib Targeting of KIT-Mutant Oncoprotein in Melanoma (2008) (125)
Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury. (1998) (124)
Papillary renal cell carcinoma. Histology and immunohistochemistry. (1995) (119)
Loss of p16 protein defines high-risk patients with gastrointestinal stromal tumors: a tissue microarray study. (2005) (118)
Adoption of a clinical pharmacogenomics implementation program during outpatient care–initial results of the University of Chicago “1,200 Patients Project” (2014) (118)
Clonal Evolution of Resistance to Imatinib in Patients with Metastatic Gastrointestinal Stromal Tumors (2007) (118)
Protein Kinase C θ (PKCθ) Expression and Constitutive Activation in Gastrointestinal Stromal Tumors (GISTs) (2004) (118)
Immunostaining of the von Hippel-Lindau gene product in normal and neoplastic human tissues. (1997) (118)
Expression of sialyl-Lewis X, an E-selectin ligand, in inflammation, immune processes, and lymphoid tissues. (1992) (117)
Ménétrier disease and gastrointestinal stromal tumors: hyperproliferative disorders of the stomach. (2007) (116)
Genome‐wide transcriptome analyses reveal p53 inactivation mediated loss of miR‐34a expression in malignant peripheral nerve sheath tumours (2010) (116)
Renal cell carcinomas in children and young adults: increased incidence of papillary architecture and unique subtypes. (1999) (116)
Bile duct injury as a major cause of stenosis and occlusion in transjugular intrahepatic portosystemic shunts: comparative histopathologic analysis in humans and swine. (1996) (115)
Late mortality after orthotopic liver transplantation. (2001) (112)
Radiofrequency ablation lesions in a pig liver model. (1999) (112)
Solid variants of papillary (chromophil) renal cell carcinoma: clinicopathologic and genetic features. (1997) (111)
Assessing copy number alterations in targeted, amplicon-based next-generation sequencing data. (2015) (109)
Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin (2001) (108)
Immunosuppression impact on long-term cardiovascular complications after liver transplantation. (2002) (106)
Phase II Study of Imatinib Mesylate in Chemotherapy Refractory Germ Cell Tumors Expressing KIT (2006) (104)
High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast (2010) (102)
Phase II Study of Nilotinib in Melanoma Harboring KIT Alterations Following Progression to Prior KIT Inhibition (2015) (101)
Exome Sequencing of Cell-Free DNA from Metastatic Cancer Patients Identifies Clinically Actionable Mutations Distinct from Primary Disease (2015) (100)
Administration of ricin induces a severe inflammatory response via nonredundant stimulation of ERK, JNK, and P38 MAPK and provides a mouse model of hemolytic uremic syndrome. (2005) (98)
Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs (2012) (97)
Gonadotropin beta subunits determine the rate of assembly and the oligosaccharide processing of hormone dimer in transfected cells (1987) (97)
Inhibition of colon carcinoma cell lung colony formation by a soluble form of E-selectin. (1997) (96)
“Pediatric-type” Gastrointestinal Stromal Tumors in Adults: Distinctive Histology Predicts Genotype and Clinical Behavior (2011) (96)
Cytomegalovirus-Mediated Upregulation of Chemokine Expression Correlates with the Acceleration of Chronic Rejection in Rat Heart Transplants (2003) (96)
Sunitinib (SU) response in imatinib-resistant (IM-R) GIST correlates with KIT and PDGFRA mutation status. (2006) (94)
In vivo Bioavailability and Pharmacokinetics of a c-MYC Antisense Phosphorodiamidate Morpholino Oligomer, AVI-4126, in Solid Tumors (2005) (93)
Percutaneous bioprosthetic venous valve: a long-term study in sheep. (2002) (91)
A molecular portrait of gastrointestinal stromal tumors: an integrative analysis of gene expression profiling and high-resolution genomic copy number (2010) (89)
Extragastrointestinal Stromal Tumors Presenting as Vulvovaginal/Rectovaginal Septal Masses: A Diagnostic Pitfall (2006) (87)
Efficacy and safety of midostaurin in patients with advanced systemic mastocytosis: 10-year median follow-up of a phase II trial (2018) (86)
Biochemical and biologic characterization of murine monocyte chemoattractant protein-1. Identification of two functional domains. (1994) (86)
Biliary tract complications of side-to-side without T tube versus end-to-end with or without T tube choledochocholedochostomy in liver transplant recipients. (1998) (85)
Crosstalk between KIT and FGFR3 Promotes Gastrointestinal Stromal Tumor Cell Growth and Drug Resistance. (2015) (84)
Long-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard tyrosine kinase inhibitor therapy. (2016) (83)
Association of fungal infection and increased mortality in liver transplant recipients. (2000) (82)
Survival in human colorectal cancer correlates with expression of the T-cell costimulatory molecule OX-40 (CD134). (2002) (81)
Multiplex mutation screening by mass spectrometry evaluation of 820 cases from a personalized cancer medicine registry. (2011) (81)
Effects of preventing O-glycosylation on the secretion of human chorionic gonadotropin in Chinese hamster ovary cells. (1987) (80)
Quadruple wild-type (WT) GIST: defining the subset of GIST that lacks abnormalities of KIT, PDGFRA, SDH, or RAS signaling pathways (2014) (79)
Gastrointestinal stromal tumors: insights from a new familial GIST kindred with unusual genetic and pathologic features. (2005) (79)
CD99, keratin, and vimentin staining of sex cord-stromal tumors, normal ovary, and testis. (1998) (78)
BRAF in Papillary Thyroid Carcinoma of Ovary (Struma Ovarii) (2007) (78)
Rhabdomyosarcomatous Differentiation in Gastrointestinal Stromal Tumors After Tyrosine Kinase Inhibitor Therapy: A Novel Form of Tumor Progression (2009) (77)
Response to imatinib mesylate of a gastrointestinal stromal tumor with very low expression of KIT (2003) (77)
Protein Kinase C theta (PKCtheta) expression and constitutive activation in gastrointestinal stromal tumors (GISTs). (2004) (76)
Colocalization of thrombospondin and syndecan during murine development (1992) (75)
Relation of tumor pathologic and molecular features to outcome after surgical resection of localized primary gastrointestinal stromal tumor (GIST): Results of the intergroup phase III trial ACOSOG Z9001. (2010) (74)
Loss of succinate dehydrogenase subunit B (SDHB) expression is limited to a distinctive subset of gastric wild‐type gastrointestinal stromal tumours: a comprehensive genotype–phenotype correlation study (2012) (74)
Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST) (2014) (74)
Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033 (2017) (74)
Vascular expression of E-selectin is increased in estrogen-receptor-negative breast cancer: a role for tumor-cell-secreted interleukin-1 alpha. (1997) (73)
Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KIT D816V. (2009) (71)
The gene expression profile of extraskeletal myxoid chondrosarcoma (2005) (68)
Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients. (2007) (68)
Vancomycin-resistant Enterococcus in liver transplant patients. (1999) (67)
Primary Extragastrointestinal Stromal Tumor of the Pleura: Report of a Unique Case With Genetic Confirmation (2010) (67)
State-of-the Art Therapy for Gastrointestinal Stromal Tumors (2005) (66)
Reconstitution of hepatitis C virus–specific T‐cell–mediated immunity after liver transplantation (2005) (65)
Expression of KIT and epidermal growth factor receptor in chemotherapy refractory non-seminomatous germ-cell tumors. (2003) (63)
Newly described activating JAK3 mutations in T-cell acute lymphoblastic leukemia (2012) (62)
A Multiplexed Amplicon Approach for Detecting Gene Fusions by Next-Generation Sequencing. (2016) (62)
Mitotic recombination as evidence of alternative pathogenesis of gastrointestinal stromal tumours in neurofibromatosis type 1 (2006) (61)
Association of cytomegalovirus genotype with graft rejection after liver transplantation. (1998) (58)
S0356: a phase II clinical and prospective molecular trial with oxaliplatin, fluorouracil, and external-beam radiation therapy before surgery for patients with esophageal adenocarcinoma. (2011) (57)
Correlation of target kinase genotype with clinical activity of imatinib mesylate (IM) in patients with metastatic GI stromal tumors (GISTs) expressing KIT (KIT (2005) (56)
KIT Inhibitor Midostaurin Exhibits a High Rate of Clinically Meaningful and Durable Responses in Advanced Systemic Mastocytosis: Report of a Fully Accrued Phase II Trial (2010) (56)
Durable Response to Afatinib in Lung Adenocarcinoma Harboring NRG1 Gene Fusions. (2017) (55)
Complex translocation [7;22] identified in an epithelioid hemangioendothelioma. (1996) (55)
KIT gene deletions at the intron 10-exon 11 boundary in GI stromal tumors. (2004) (53)
Apoptosis-stimulating protein of p53 (ASPP2) heterozygous mice are tumor-prone and have attenuated cellular damage–response thresholds (2009) (52)
Gastrointestinal stromal tumors: molecular markers and genetic subtypes. (2013) (52)
Imatinib in the management of multiple gastrointestinal stromal tumors associated with a germline KIT K642E mutation. (2007) (51)
Protein kinase A RII-like (R2D2) proteins exhibit differential localization and AKAP interaction. (2008) (51)
Elimination of donor-specific alloreactivity prevents cytomegalovirus-accelerated chronic rejection in rat small bowel and heart transplants. (2002) (51)
A comparison of hepatopathologists' and community pathologists' review of liver biopsy specimens from patients with hepatitis C. (2009) (50)
Hepatic allograft abscess with hepatic arterial thrombosis. (1998) (48)
MAX inactivation is an early event in GIST development that regulates p16 and cell proliferation (2017) (48)
Sentinel lymph node staging of cutaneous melanoma: predictors and outcomes. (2010) (48)
Human Cytomegalovirus Infection of Caco-2 Cells Occurs at the Basolateral Membrane and Is Differentiation State Dependent (1999) (48)
Immunohistochemistry of unclassified sex cord-stromal tumors of the testis with a predominance of spindle cells. (1997) (48)
KRAS and KIT Gatekeeper Mutations Confer Polyclonal Primary Imatinib Resistance in GI Stromal Tumors: Relevance of Concomitant Phosphatidylinositol 3-Kinase/AKT Dysregulation. (2015) (47)
Primary adenoid cystic carcinoma of the lung (2007) (47)
Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: A diagnostic challenge (2010) (45)
Randomized study of high-dose pulse calcitriol or placebo prior to radical prostatectomy. (2004) (44)
Epithelioid gastric stromal tumours of the antrum in young females with the Carney triad: a report of three new cases with mutational analysis and comparative genomic hybridization. (2007) (44)
NTRK gene rearrangements are highly enriched in MLH1/PMS2 deficient, BRAF wild-type colorectal carcinomas—a study of 4569 cases (2019) (43)
Novel Mutations in Neuroendocrine Carcinoma of the Breast: Possible Therapeutic Targets (2015) (43)
Donor polymorphism of tumor necrosis factor gene: relationship with variable severity of hepatitis C recurrence after liver transplantation. (1999) (41)
Mucinous breast carcinomas lack PIK3CA and AKT1 mutations. (2012) (41)
Frequent phosphatidylinositol-3-kinase mutations in proliferative breast lesions (2014) (41)
Phosphatidylinositol-3-kinase pathway mutations are common in breast columnar cell lesions (2012) (39)
Leiomyoma of the Gastrointestinal Tract With Interstitial Cells of Cajal: A Mimic of Gastrointestinal Stromal Tumor (2014) (39)
Novel Biomarker Candidates to Predict Hepatic Fibrosis in Hepatitis C Identified by Serum Proteomics (2011) (38)
Allele-specific polymerase chain reaction for the imatinib-resistant KIT D816V and D816F mutations in mastocytosis and acute myelogenous leukemia. (2006) (38)
Evaluation of rapid antibody tests for the diagnosis of helicobacter pylori infection (2000) (38)
Absence of BRAF, NRAS, KRAS, HRAS Mutations, and RET/PTC Gene Rearrangements Distinguishes Dominant Nodules in Hashimoto Thyroiditis from Papillary Thyroid Carcinomas (2010) (37)
Long-term follow-up of a phase II randomized trial in advanced gastrointestinal stromal tumor (GIST) patients (pts) treated with imatinib mesylate. (2006) (37)
Gonadotropin alpha subunit. Differential processing of free and combined forms in human trophoblast and transfected mouse cells. (1987) (35)
A nonrandom association of gastrointestinal stromal tumor (GIST) and desmoid tumor (deep fibromatosis): case series of 28 patients. (2012) (35)
Fatal Fulminant Hepatitis Associated with Bromfenac Use (1999) (35)
Recurrent RET gene fusions in paediatric spindle mesenchymal neoplasms* (2020) (35)
Distinctive Morphology of Renal Cell Carcinomas in Tuberous Sclerosis (2010) (34)
Tolerance induced by bone marrow chimerism prevents transplant vascular sclerosis in a rat model of small bowel transplant chronic rejection. (2000) (34)
Noninvasive tests as a substitute for histology in the diagnosis of Helicobacter pylori infection. (2000) (33)
Remodeling of suspended small intestinal submucosa venous valve: an experimental study in sheep to assess the host cells' origin. (2003) (33)
Immunohistochemical and Molecular Markers in Breast Phyllodes Tumors (2011) (33)
Oncogenic mutations in melanomas and benign melanocytic nevi of the female genital tract. (2014) (33)
Expression Analysis of Barrett's Esophagus–Associated High-Grade Dysplasia in Laser Capture Microdissected Archival Tissue (2008) (32)
BRAF and KRAS Mutations in Sporadic Glomus Tumors (2012) (32)
Implementing a comprehensive translational oncology platform: from molecular testing to actionability (2018) (31)
A rat small bowel transplant model of chronic rejection: histopathologic characteristics. (1999) (30)
The role of molecular markers and tumor histological type in central lymph node metastasis of papillary thyroid carcinoma. (2012) (30)
An activating KRAS mutation in imatinib-resistant chronic myeloid leukemia (2008) (29)
A multicenter phase II study of regorafenib in patients (pts) with advanced gastrointestinal stromal tumor (GIST), after therapy with imatinib (IM) and sunitinib (SU). (2011) (29)
Differential secretion of O-glycosylated gonadotropin alpha-subunit and luteinizing hormone (LH) in the presence of LH-releasing hormone. (1985) (28)
Acute and Chronic Renal Effects of Recombinant Human TGF-β2 in the Rat (1999) (28)
Effects of Blood Flow and/or Ventilation Restriction on Radiofrequency Coagulation Size in the Lung: An Experimental Study in Swine (2006) (28)
Gene expression of the IGF pathway family distinguishes subsets of gastrointestinal stromal tumors wild type for KIT and PDGFRA (2013) (28)
Primary melanoma of the spinal cord: a case report, molecular footprint, and review of the literature. (2011) (27)
Circulating tumor DNA dynamics using patient-customized assays are associated with outcome in neoadjuvantly treated breast cancer (2019) (27)
Mutation profiling in gallbladder cancer in Indian population. (2014) (27)
Novel BRAF gene fusions and activating point mutations in spindle cell sarcomas with histologic overlap with infantile fibrosarcoma (2021) (27)
Outcome following surgical therapy for gastrointestinal stromal tumors (2006) (27)
Personalized Cancer Diagnostics (2011) (26)
SHIFT: speedy histological-to-immunofluorescent translation of a tumor signature enabled by deep learning (2020) (26)
Sentinel node staging of primary melanoma by the "10% rule": pathology and clinical outcomes. (2007) (26)
Interobserver agreement in hepatitis C grading and staging and in the Banff grading schema for acute cellular rejection: the "hepatitis C 3" multi-institutional trial experience. (2006) (26)
Resistance of prostate cancer cell lines to COX-2 inhibitor treatment. (2005) (26)
KIT gene mutations in gastrointestinal stromal tumors: more complex than previously recognized? (2002) (25)
Cap-assisted endoscopic submucosal resection of a pancreatic rest. (2001) (24)
Noninvasive imaging of melanoma with reflectance mode confocal scanning laser microscopy in a murine model. (2007) (24)
Hepatic iron overload: direct HFE (HLA-H) mutation analysis vs quantitative iron assays for the diagnosis of hereditary hemochromatosis. (1998) (24)
Serum leptin levels, hepatic leptin receptor transcription, and clinical predictors of non-alcoholic steatohepatitis in obese bariatric surgery patients (2007) (23)
SDHC methylation in gastrointestinal stromal tumors (GIST): a case report (2015) (23)
Tumor necrosis factor‐α promoter polymorphisms and the risk of rejection after liver transplantation: A case control analysis of 210 donor‐recipient pairs (2003) (23)
Rare expression of KIT and absence of KIT mutations in high grade renal cell carcinoma. (2006) (23)
Using molecular diagnostic testing to personalize the treatment of patients with gastrointestinal stromal tumors (2017) (23)
Tackling formalin-fixed, paraffin-embedded tumor tissue with next-generation sequencing. (2012) (23)
Differential expression of neural markers in KIT and PDGFRA wild‐type gastrointestinal stromal tumours (2011) (23)
Attempted induction of chronic portal venous hypertension with polyvinyl alcohol particles in swine. (1997) (22)
Mechanisms of sunitinib malate (SU) resistance in gastrointestinal stromal tumors (GISTs) (2007) (22)
Novel method for PIK3CA mutation analysis: locked nucleic acid--PCR sequencing. (2013) (22)
Comparison of the endothelialization of small intestinal submucosa, dacron, and expanded polytetrafluoroethylene suspended in the thoracoabdominal aorta in sheep. (2006) (21)
Hepatic and cardiac iron overload among patients with end‐stage liver disease referred for liver transplantation (2010) (21)
Small intestinal submucosa covered expandable Z stents for treatment of tracheal injury: an experimental pilot study in swine. (2000) (21)
The KIT Tyrosine Kinase Inhibitor Midostaurine (PKC412) Exhibits a High Response Rate in Aggressive Systemic Mastocytosis (ASM): Interim Results of a Phase II Trial. (2007) (21)
Genomic aberrations in cell cycle genes predict progression of KIT-mutant gastrointestinal stromal tumors (GISTs) (2019) (21)
Dose-escalation study of a second-generation non-ansamycin HSP90 inhibitor, onalespib (AT13387), in combination with imatinib in patients with metastatic gastrointestinal stromal tumour. (2016) (21)
Generation of anti-insulin-like growth factor-binding protein-related protein 1 (IGFBP-rP1/MAC25) monoclonal antibodies and immunoassay: quantification of IGFBP-rP1 in human serum and distribution in human fluids and tissues. (2003) (20)
OX40 (CD134) expression in sentinel lymph nodes correlates with prognostic features of primary melanomas. (2008) (19)
Multiplex high-throughput gene mutation analysis in acute myeloid leukemia. (2012) (19)
Genetic Profiling to Determine Risk of Relapse-Free Survival in High-Risk Localized Prostate Cancer (2013) (19)
Biliary Adenofibroma of Liver: Morphology, Tumor Genetics, and Outcomes in 6 Cases (2017) (19)
IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma (2015) (18)
Molecular determinants of response to matuzumab in combination with paclitaxel for patients with advanced non-small cell lung cancer (2009) (18)
Pathological documentation of complete elimination of Barrett's metaplasia following endoscopic multipolar electrocoagulation therapy (2001) (18)
c-CBL is not required for leukemia induction by Bcr-Abl in mice (2003) (18)
A canine model for studying endoleak after endovascular aneurysm repair. (2003) (18)
The novel monoclonal antibody HPC2 and N-cadherin distinguish pancreatic ductal adenocarcinoma from cholangiocarcinoma. (2012) (17)
ELIMINATION OF DONOR-SPECIFIC ALLOREACTIVITY BY BONE MARROW CHIMERISM PREVENTS CYTOMEGALOVIRUS ACCELERATED TRANSPLANT VASCULAR SCLEROSIS IN RAT SMALL BOWEL TRANSPLANTS (1999) (17)
A DNA methylation microarray-based study identifies ERG as a gene commonly methylated in prostate cancer (2011) (17)
JNCCN NCCN Task Force Report : Optimal Management of Patients with Gastrointestinal Stromal Tumor ( GIST ) — Update of the NCCN Clinical Practice Guidelines (2007) (17)
Angiotensin II Type 1 and 2 Receptors in Conduit Arteries of Normal Developing Microswine (2002) (17)
The square stent-based large vessel occluder: an experimental pilot study. (2000) (17)
PIK3CA-AKT pathway mutations in micropapillary breast carcinoma. (2013) (16)
Biphasic Papillary and Lobular Breast Carcinoma With PIK3CA and IDH1 Mutations (2012) (16)
Pediatric eosinophilic esophagitis: Single‐center experience in northwestern USA (2009) (16)
Expression of FAP, ADAM12, WISP1, and SOX11 is heterogeneous in aggressive fibromatosis and spatially relates to the histologic features of tumor activity (2013) (16)
The value of traditional upper endoscopy as a diagnostic test for Barrett's esophagus. (2008) (16)
Assessing the prognosis of gastrointestinal stromal tumors: a growing role for molecular testing. (2004) (16)
Sunitinib treatment of pediatric metastatic GIST after failure of imatinib. (2006) (16)
MDM2 Amplification and PI3KCA Mutation in a Case of Sclerosing Rhabdomyosarcoma (2013) (16)
Frequent PIK3CA Mutations in Radial Scars (2013) (16)
Long-term disease control of advanced gastrointestinal stromal tumors (GIST) with imatinib (IM): 10-year outcomes from SWOG phase III intergroup trial S0033. (2014) (15)
Liver transplantation for disulfiram-induced hepatic failure (1998) (15)
Next-Generation Sequencing in Cancer Diagnostics. (2016) (15)
Accuracy of pathologic examination in detection of complete response after chemoradiation for esophageal cancer. (2007) (15)
A phase II study of imatinib for advanced melanoma patients with KIT aberrations. (2010) (14)
Loss of the PTCH1 tumor suppressor defines a new subset of plexiform fibromyxoma (2019) (14)
Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity. (2016) (14)
Dotlike or Golgi-like KIT and PDGFRA Staining in GISTs. (2009) (13)
Aortic and venous valve for percutaneous insertion (2000) (13)
Small intestinal submucosa aneurysm sac embolization for endoleak prevention after abdominal aortic aneurysm endografting: a pilot study in sheep. (2004) (13)
Neurofibromatosis type 1-associated wild-type gastrointestinal stromal tumor treated with anti-IGF-1R monoclonal antibody (2011) (12)
DONOR POLYMORPHISM OF TUMOR NECROSIS FACTOR GENE (1999) (12)
Establishment of Patient-Derived Succinate Dehydrogenase–Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic Response (2021) (12)
An Activating KRAS Mutation in Imatinib Resistant Chronic Myeloid Leukemia. (2007) (12)
Tacrolimus is associated with a lower incidence of cardiovascular complications in liver transplant recipients. (2002) (12)
Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics (2021) (12)
Prolonged survival and disease control in the academic phase II trial of regorafenib in GIST: Response based on genotype. (2013) (11)
Infantile fibrosarcoma with a novel RAF1 rearrangement: The contemporary challenge of reconciling classic morphology with novel molecular genetics (2020) (11)
Graft Failure From Severe Recurrent Primary Sclerosing Cholangitis Following Orthotopic Liver Transplantation (2003) (11)
Biochemical, Molecular, and Clinical Characterization of Succinate Dehydrogenase Subunit A Variants of Unknown Significance (2017) (10)
The epidemic of prostate cancer and the medical literature: a causal association? (1998) (10)
Evaluation of the presence of IGF1R overexpression in wild-type and kinase mutant GI stromal tumors. (2009) (10)
Oxaliplatin (OXP) plus protracted infusion 5-fluorouracil (PIFU) and external beam radiation (EBRT) prior to surgery (S) for potentially curable esophageal adenocarcinoma (EA): A Southwest Oncology Group (SWOG) phase II trial with molecular correlates (S0356). (2016) (10)
GAB1‐ABL1 fusions in tumors that have histologic overlap with NTRK‐rearranged spindle cell tumors (2021) (10)
A nonrandom association of gastrointestinal stromal tumor (GIST) and desmoid tumor (deep fibromatosis): case series of 28 patients. (2012) (10)
A phase II trial of neoadjuvant dasatinib (Neo-D) in muscle-invasive urothelial carcinoma of the bladder (miUCB): Hoosier Oncology Group GU07-122 trial. (2012) (10)
Gastrointestinal stromal tumours of the oesophagus: a clinicopathological and molecular analysis of 27 cases (2017) (10)
Conjoined hyperactivation of the RAS and PI3K pathways in advanced GIST. (2016) (9)
Metastatic breast cancer manifested as refractory anemia and gastric polyps. (2002) (9)
S0502: A SWOG Phase III Randomized Study of Imatinib, With or Without Bevacizumab, in Patients With Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors. (2015) (9)
Utility of BRAF V600E mutation-specific immunohistochemistry in detecting BRAF V600E-mutated gastrointestinal stromal tumors. (2015) (9)
Acute and chronic renal effects of recombinant human TGF-beta2 in the rat. (1999) (9)
An omic and multidimensional spatial atlas from serial biopsies of an evolving metastatic breast cancer (2020) (9)
Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapies (2021) (8)
Multi-Institutional Evaluation of Inter-rater Agreement of Variant Classification Based on the 2017 AMP, ASCO and CAP Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer. (2019) (8)
Evaluation of imatinib mesylate (IM) in patients with large volume gastrointestinal stromal tumors (GISTs) (2007) (8)
Breast cancer histopathology image analysis pipeline for tumor purity estimation (2017) (8)
Hybrid Capture 2 is as Effective as PCR Testing for High-risk Human Papillomavirus in Head and Neck Cancers (2015) (7)
Cancer: Oncogenes in context (2010) (7)
Elderly Former Smoker with HRAS Mutant Non–Small-Cell Lung Cancer (2014) (7)
Insulin-like growth factor 1 receptor (IGF-1R): A potential therapeutic target for gastrointestinal stromal tumors (GIST) (2008) (7)
Percutaneous transjugular kidney biopsy in swine with use of a side-cutting needle with a blunt-tipped stylet. (1999) (7)
Endoluminal Treatment of Ruptured Abdominal Aortic Aneurysm with Small Intestinal Submucosa Sandwich Endografts: A Pilot Study in Sheep (2001) (7)
A case of recurrent epilepsy‐associated rosette‐forming glioneuronal tumor with anaplastic transformation in the absence of therapy (2019) (7)
Custom (Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies) trial. (2013) (6)
Multi-Institutional Evaluation of Interrater Agreement of Variant Classification Based on the 2017 Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Ca (2020) (6)
Colorectal Cancer-Associated Spontaneous Tumor Lysis Syndrome: a Case Report and Review of the Current Literature (2019) (6)
Effects of preventing 0-glycosylation on the secretion of human chorionic gonadotropin in Chinese hamster ovary cells (6)
Molecular Testing in Patients With Castration-Resistant Prostate Cancer and Its Impact on Clinical Decision Making. (2017) (6)
Post‐treatment hypermutation in a recurrent diffuse glioma with H3.3 p.G34 Mutation (2020) (6)
Novel Mutations in Neuroendocrine Carcinoma of the Breast: Possible Therapeutic Targets. (2014) (6)
28 Molecular and clinical analysis of response to imatinib for locally advanced dermatofibrosarcoma protuberans (2004) (5)
Pharmacoeconomic study of tacrolimus-based versus cyclosporine-based immunosuppressive therapy following liver transplantation. (2001) (5)
Prevalence and Predictors of Hepatic Steatosis in Adults With Newly Diagnosed Chronic Liver Disease due to Hepatitis C (2009) (5)
Location of Gastrointestinal Stromal Tumor (GIST) in the Stomach Predicts Tumor Mutation Profile and Drug Sensitivity (2021) (5)
Mechanisms of targeted therapy resistance in a pediatric glioma driven by ETV6-NTRK3 fusion (2021) (5)
When yellow jackets attack: Recurrent and severe anaphylactic reactions to insect bites and stings (2009) (5)
Disease-free Interval Is Associated with Oncologic Outcomes in Patients with Recurrent Gastrointestinal Stromal Tumor (2021) (4)
Determining barriers to effective data sharing in cancer genomic sequencing initiatives: A Global Alliance for Genomics and Health (GA4GH) survey. (2016) (4)
Primary scrotal melanoma presenting as a large, amelanotic, exophytic mass. (2009) (4)
Template for Reporting Results of Biomarker Testing of Specimens From Patients With Gastrointestinal Stromal Tumors. (2015) (4)
Targeting mutant kinases in gastrointestinal stromal tumors: a paradigm for molecular therapy of other sarcomas. (2004) (4)
Isolated jejunal Crohn's disease in a young woman presenting with malabsorption syndrome and abdominal pain. (1997) (4)
Retrievable IVC square stent filter: Experimental study (1999) (4)
Mapping cancer signaling networks by an integrated multiplexed tissue imaging platform (2016) (4)
Abstract LB-282: Ex vivo 3d drug response profiling of primary human ovarian cancer differentiates treatment-naive and relapsed patients and molecular subtypes (2015) (4)
Discordant Mutations in Paired Primary and Metastatic Endometrial Adenocarcinomas Identified by Semiconductor-Based Sequencing for Rapid Cancer Genotyping (2016) (4)
CHAPTER 1 – Endothelial-Leukocyte Adhesion Molecule-1 (ELAM-1): A Vascular SELECTIN That Regulates Inflammation (1991) (4)
TREATMENT OF PROGRESSIVE HCV RECURRENCE POST LIVER TRANSPLANTATION WITH COMBINATION INTERFERON PLUS RIBAVIRIN.: Abstract# 770 Poster Board #‐Session: P27‐III (2000) (4)
Functional impact and targetability of PI3KCA, GNAS, and PTEN mutations in a spindle cell rhabdomyosarcoma with MYOD1 L122R mutation (2022) (4)
Abstract 5301: Integrated array CGH and expression profiling revealed candidate biomarkers in gastrointestinal stromal tumors. (2013) (4)
A class of ompA mutants of Escherichia coliK12 affected in the interaction of OmpA protein and the core region of lipopolysaccharide (2004) (3)
Does tumor mutational status correlate with clinical response to imatinib? (2006) (3)
Embryonal rhabdomyosarcoma in a 3-year-old child diagnosed at ERCP: case report and review. (2002) (3)
Percutaneous Vein Occlusion with Small Intestinal Submucosa: An Experimental Pilot Study in Swine and Sheep (2007) (3)
Experimental Percutaneous Extrahepatic Portacaval Shunt Creation by Transjugular Approach in Swine (2005) (3)
Feasibility of real-time serial comprehensive tumor analytics: Pilot study of olaparib and durvalumab in metastatic triple negative breast cancer (mTNBC). (2020) (3)
SWOG S0809: A phase II trial of adjuvant capecitabine (cap)/gemcitabine (gem) followed by concurrent capecitabine and radiotherapy in extrahepatic cholangiocarcinoma (EHCC) and gallbladder carcinoma (GBCA). (2014) (3)
Inhibition of KIT Tyrosine Kinase Activity: Two Decades After the First Approval. (2021) (3)
Prophylactic antiviral therapy in CMV high-risk liver transplant recipients. (2001) (3)
Defining the Impact of Adjuvant Therapy in Molecularly Defined Subsets of Gastrointestinal Stromal Tumor : From Lumping to Splitting. (2017) (3)
SHIFT: speedy histological-to-immunofluorescent translation of whole slide images enabled by deep learning (2019) (3)
Kinase Mutat ions and Imat inib Response in Pat ients With Metastat ic Gastro intes t inal Stromal Tumor (2003) (3)
The signature program, a series of tissue-agnostic, mutation-specific signal finding trials. (2014) (3)
An Integrated Clinical, Omic, and Image Atlas of an Evolving Metastatic Breast Cancer (2020) (3)
KIT as a Therapeutic Target (2003) (3)
Oncogenic receptor tyrosine kinase (RTK) translocations in a subset of quadruple wild-type gastrointestinal stromal tumors (GIST). (2016) (3)
Human pancreatic cancer fusion 2 (HPC2) 1‐B3: A novel monoclonal antibody to screen for pancreatic ductal dysplasia (2013) (3)
Predicting primary site of secondary liver cancer with a neural estimator of metastatic origin (2020) (3)
Impact of next-generation sequencing (NGS) on treatment decisions in the community oncology setting. (2014) (2)
HSP90 inhibitor STA‐9090 potently suppresses secondary KIT kinase‐domain mutations responsible for gastrointestinal stromal tumor (GIST) progression during imatinib therapy (2010) (2)
In reply [10] (2007) (2)
Mass spectroscopy-based cancer genotyping of 800 patients enrolled in a personalized cancer medicine registry. (2010) (2)
High-throughput mutation analysis in acute myeloid leukemia (AML). (2011) (2)
328 Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumors) (2004) (2)
RAS mutations in therapy-related acute myeloid leukemia after successful treatment of acute promyelocytic leukemia (2012) (2)
Abstract 1121: Profiling patient-specific glioblastoma drug responsein vitrousing complex 3D microtumors (2018) (2)
Evaluating early-stage prostate cancer. What pretreatment criteria best guide therapeutic decision making? (1996) (2)
252 Polyclonal resistance to kinase inhibition in GIST: Mechanisms and therapeutic strategies (2010) (2)
Low-grade Osteosarcomatous Dedifferentiation of an Atypical Lipomatous Tumor in a Pediatric Patient (2019) (2)
Correlation of KIT and PDGFRA mutation status with sunitinib activity in imatinib-resistant GIST (2006) (1)
Neoadjuvant tyrosine kinase inhibitor therapy for patients with gastrointestinal stromal tumor: A propensity-matched analysis. (2022) (1)
Nuclear Grooves in Papillary (Chromophil) Renal Cell Carcinoma (1998) (1)
Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST) (2014) (1)
Predictors of early relapse in high risk prostate cancer patients treated with neoadjuvant mitoxantrone and docetaxel (2005) (1)
Multi-omics analysis of serial samples from metastatic TNBC patients on PARP inhibitor monotherapy provide insight into rational PARP inhibitor therapy combinations (2020) (1)
Hepatic metastases in gastrointestinal stromal tumors: oncologic outcomes with curative-intent hepatectomy, resection of treatment-resistant disease, and tyrosine kinase inhibitor therapy alone. (2021) (1)
Small-Molecule Inhibitors of Protein Kinases in the Treatment of Human Cancer (2003) (1)
Association of excision repair cross-complementation group 1 (ERCC1) gene expression (GE) with outcome in stage II-III esophageal adenocarcinoma (EA) patients treated with preoperative platinum-based chemoradiation (CRT) in a phase II cooperative study (SWOG 0356). (2011) (1)
Utility of Multiplex Mutation Analysis in the Diagnosis of Chronic Myelomonocytic Leukemia (2013) (1)
PDGF Receptors as Therapeutic Targets (2003) (1)
Exceptional Response to Trastuzumab in a Heavily Pretreated Patient With ERBB3-Mutated Metastatic Breast Cancer. (2021) (1)
Single-Cell Proteomics Analysis of Recurrent Low-Grade Serous Ovarian Carcinoma and Associated Brain Metastases (2022) (1)
93 Ganciclovir does not increase the risk of HCV recurrence after liver transplantation (2000) (1)
Diagnosis ofGastrointestinal StromalTumors: A ConsensusApproach (2002) (1)
Acute and Chronic Renal Effects of Recombinant Human TGF- b 2 in the Rat (2000) (1)
Ten-Year Survivorship in Patients with Metastatic Gastrointestinal Stromal Tumors (2022) (1)
Significant response to trametinib in a woman with recurrent KRAS-mutated low-grade serous carcinoma of the ovary-a case report (2015) (1)
584 Proteomics to predict hepatitis C fibrosis (2003) (1)
ASO Visual Abstract: The Disease-Free Interval is Associated with Oncologic Outcomes in Patients with Recurrent Gastrointestinal Stromal Tumor (2021) (1)
Coexistence of gastrointestinal stromal tumor (GIST) with desmoid tumor (DT): Case series of 22 patients. (2010) (1)
Genome-wide transcriptome analysis of nerve sheath tumors (2006) (1)
Association of excision repair cross-complementation group 1 (ERCC1) gene expression (GE) with outcome in stage II-III esophageal adenocarcinoma (EA) patients treated with preoperative platinum-based chemoradiation (CRT) in a phase II cooperative group study (SWOG S0356). (2011) (1)
Multiomics profiling of longitudinal melanoma specimens unravels molecular mechanisms of resistance to sequential targeted and cancer immunotherapies. (2020) (1)
Toxicity of TKIs (2003) (0)
Pilot trial of molecular profiling and targeted therapies in advanced thoracic malignancies: Non-small cell lung cancer, small cell lung cancer and thymic malignancies (CUSTOM). (2012) (0)
7503 ORAL KIT mutations and sunitinib resistance in gastrointestinal stromal tumors (GISTs) (2007) (0)
The Novel Monoclonal Antibody HPC2 and N-cadherin Distinguish Metastatic Pancreatic Ductal Adenocarcinoma from Cholangiocarcinoma (2013) (0)
Prevalence of hereditary GIST susceptibility in adults with GIST. (2011) (0)
Short term safety and efficacy of famciclovir in prevention of CMV infection in liver transplant recipients (1998) (0)
Molecular Markers and Genetic Subtypes (2013) (0)
AWARD NUMBER: DAMD17-03-1-0297 TITLE: Genomic and Expression Profiling of Benign & Malignant Nerve Sheath Tumors in Neurofibromatosis Patients (0)
Abstract TMIM-069: PROSPECTIVE CLINICAL VALIDATION OF EX VIVO, PATIENT-SPECIFIC RESPONSE PREDICTION TO FIRST-LINE CHEMOTHERAPY (2019) (0)
Utilisation de 4-(4-methylpiperazine-1-ylmethyl)-n[4-methyl-3-(4-pyridine-3-yl)pyrimidine-2-ylamino)phenyl]-benzamide dans le traitement de seminomes (2003) (0)
Transfer Learning for Inference of Metastatic Origin from Whole Slide Histology (2021) (0)
8 – Cancer of the Genitourinary Tract (2010) (0)
Abstract OT-16-01: A phase 1 study of abemaciclib and niraparib as neoadjuvant therapy in hormone receptor positive (HR+) HER2 negative (HER2-) breast cancer (2021) (0)
AN ABSTRACT OF THE THESIS OF Marc A. Kinsley for the degree of Master of Science in Veterinary Science presented on June 4, 2013 Title: Molecular Characterization of Wnt/β-catenin Signaling in Early Equine Osteochondrosis (2013) (0)
Imaging , Diagnosis , Prognosis Genetic Pro fi ling to Determine Risk of Relapse-Free Survival in High-Risk Localized Prostate Cancer (2014) (0)
CMV GENOTYPIC VARIABILITY AFFECTS RATE OF REJECTION BUT NOT SURVIVAL AFTER LIVER TRANSPLANTATION. (1998) (0)
Scientific paper Sentinel node staging of primary melanoma by the "10% rule": pathology and clinical outcomes (2007) (0)
NATURAL HISTORY OF HEPATITIS C RECURRENCE IN ORTHOTOPIC LIVER TRANSPLANT RECIPIENTS FOR HEPATITIS C ALONE VS HEPATITIS C AND ALCOHOLIC CIRRHOSIS (1998) (0)
normal microswine receptors in developing kidney of (2016) (0)
NOTES ON BOOKS (1975) (0)
Considerations in Clinical Trial Design for Tyrosine Kinase Inhibitors (2003) (0)
ASPP2 Haploinsufficiency Promotes Tumor Formation in a Mouse Model. (2006) (0)
ARG (Abelson-Related Gene) as a Therapeutic Target (2003) (0)
HELIX-ICC: An-open label phase II trial of induction systemic mFOLFIRINOX followed by concurrent hepatic arterial infusion of floxuridine and systemic mFOLFIRI for unresectable intrahepatic cholangiocarcinoma. (2022) (0)
CYTOMEGALOVIRUS (CMV)-ACCELERATED TRANSPLANT VASCULAR SCLEROSIS(TVS): REQUIREMENT FOR ALLOREACTIVITY (1998) (0)
FGFR1 and NTRK3 actionable alterations in “Wild-Type” gastrointestinal stromal tumors (2016) (0)
Integrate whole genomic study of KIT/PDGFRA wild-type (WT) GIST. (2014) (0)
Biliary small intestinal submucosa covered Z-stents: Preliminary results in an animal model (2001) (0)
Accuracy in Endoscopic Diagnosis of Barrett's Esophagus (2007) (0)
Abstract 4929: Leveraging multi-omics tumor boards for precision medicine in the OHSU SMMART Treatments Program (2019) (0)
Molecular epidemiology of gastrointestinal stromal tumors (GISTs): comparison of North and South American patient populations (2008) (0)
Case report: Novel PIK3CA and AXIN1 mutations in acinar cell carcinoma of the stomach arising from pancreatic heterotopia (2021) (0)
Apoptosis Stimulating Protein of p53 (ASPP2) Heterozygous Mice Are Lymphoma-Prone and Display Attenuated Apoptosis and Cell Cycle Checkpoints (2008) (0)
Effects ofpreventing 0-glycosylation onthesecretion ofhuman chorionic gonadotropin inChinese hamster ovarycells (glycoprotein/posttranslatlonal modiflcation/O-linked) (1987) (0)
Comment on the Article by Chetty et al on Combined Classical Carcinoid and Goblet Cell Carcinoid Tumor : A New Morphologic Variant of Carcinoid Tumor of the Appendix (2011) (0)
Effect of Chemoradiation on Survival of Resected Pancreatic Ductal Adenocarcinoma with Close or Positive Margins (2009) (0)
Practical Gastrointestinal Oncology Correlative Science (2011) (0)
Molecular profiling of metastatic castration-resistant prostate cancer (mCRPC): Preliminary results from the SU2C/PCF/AACR West Coast Prostate Cancer Dream Team (WCDT). (2014) (0)
Implementing a comprehensive translational oncology platform: from molecular testing to actionability (2018) (0)
Strategies to Inhibit Tyrosine Kinases (2003) (0)
Expression ofMitogen-Activate d (1996) (0)
Abstract LB-046: Evaluation of an assay for on-demand and easy assessment of MGMT gene promoter methylation in glioblastoma patients (2017) (0)
Chlamydia pneumoniae infection accelerates rat cardiac allograft chronic rejection but does not impact graft survival in the absence of alloreactivity (2008) (0)
Assay for threonine-linked carbohydrate in uncombined gonadotropin alpha subunit (1984) (0)
Abstract 480: Biospecimen management for the serial measurement of molecular and architectural responses to therapy (2019) (0)
Kinase M utations a nd I matinib R esponse i n P atients W ith Metastatic G astrointestinal S tromal T umor (2003) (0)
932 ASSESSMENT OF MUTATIONAL FREQUENCY IN UROTHELIAL CARCINOMA BY MULTIPLEX PCR/MASS SPECTROSCOPY ANALYSIS (2013) (0)
Tumor genotype and clinical outcomes for 229 patients with non-small cell lung cancer. (2013) (0)
Vancomycin-resistant enterococci in livertransplant recipients (2000) (0)
Abstract P2-08-03: Phosphatidylinositol-3-kinase mutations are common in lobular neoplasia (2012) (0)
Comparison of gastritis grading scales for the diagnosis of helicobacter pylori (HP) infection (2000) (0)
ERCC1 gene expression is associated with outcome in stage II-III esophageal adenocarcinoma patients treated with preoperative platinum-based chemoradiation in a phase II cooperative group study (S0356) (2008) (0)
RITUXIMAB IS SAFE AND EFFECTIVE FOR THE TREATMENT OF POST TRANSPLANT LYMPHOPROLIFERATIVE DISEASE.: Abstract# 803 Poster Board #‐Session: P60‐III (2000) (0)
Sequence data analysis and the clinical genomics database (2016) (0)
193Liver transplantation in American veterans (2000) (0)
Abstract 5641: Single cell spatial molecular imaging of 76-plex proteins in clinical cancer samples in response to personalized treatment (2023) (0)
Abstract 2149: Biomarker-driven selection of polyADP ribose polymerase inhibitors (PARPi)-based combination therapies in patients with metastatic triple negative breast cancer (mTNBC) (2022) (0)
Genomic alterations of KIT in acral and mucosal melanomas (2008) (0)
P2-06-04: Phosphatidylinositol-3-Kinase Pathway Mutations Are Common in Breast Columnar Cell Lesions. (2011) (0)
Erythrocyte fatty acids and fatty acid synthase expression in benign and malignant prostate (2008) (0)
Mutations d'activation de pdgfra (platelet derived growth factor receptor alpha) servant de marqueurs diagnostiques et cibles therapeutiques (2003) (0)
Timing and severity of initial HCV recurrence as predictors of ultimate allograft injury (1996) (0)
172 Novel Potential Markers of High Grade Dysplasia in Barrett's Esophagus Identified By cDNA Microarray Analysis of Laser Capture Microdissected Archival Tissue (2008) (0)
Abstract 4837: Development of an in vitro 3D glioblastoma model system for patient-specific drug response profiling (2017) (0)
The Role of CRELD1 Isoform 9B in the Pathogenesis of Breast Cancer (2005) (0)
Apoptosis Stimulating Protein of p53 (ASPP2) Haploinsufficiency Promotes Irradiation-Induced High Grade Lymphomas in a Mouse Model. (2007) (0)
59 – Molecular Pathology (2015) (0)
Loss of the PTCH1 tumor suppressor defines a new subset of plexiform fibromyxoma (2019) (0)
GANCICLOVIR DOES NOT INCREASE THE RISK OF HCV RECURRENCE AFTER LIVER TRANSPLANTATION.: Abstract# 797 Poster Board #‐Session: P54‐III (2000) (0)
Accuracy of Endoscopic Ultrasound for Nodal Staging of Early Esophageal Cancer (2009) (0)
Corrigendum: Functional impact and targetability of PI3KCA, GNAS, and PTEN mutations in a spindle cell rhabdomyosarcoma with MYOD1 L122R mutation. (2022) (0)
Treatment of progenessive HCV recurrence post liver transplantation with combination interferon plus Ribavirin (2000) (0)
Evaluation of an Assay for MGMT Gene Promoter Methylation in Glioblastoma Samples (2020) (0)
Predicting Primary Site of Secondary Liver Cancer with a Neural Estimator of Metastatic Origin (NEMO) (2019) (0)
7506 ORAL Up to 6 years follow-up of patients receiving imatinib mesylate (Glivec) to treat unresectable or metastatic gastrointestinal stromal tumors (GISTs) (2007) (0)
Cell cycle dysregulation is required for gastrointestinal stromal tumor (GIST) progression to high-risk disease but not for resistance to kinase inhibitors (2014) (0)
1112PPHASE II STUDY OF NILOTINIB IN MELANOMA HARBORING KIT ALTERATIONS FOLLOWING PROGRESSION OR INTOLERANCE TO PRIOR KIT INHIBITION. (2014) (0)
Heart Transplants Acceleration of Chronic Rejection in Rat Chemokine Expression Correlates with the Cytomegalovirus-Mediated Upregulation of (2002) (0)
Combining semiconductor-based sequencing with amplicon-based cancer gene panels: A rapid next-gen approach to clinical cancer genotyping. (2012) (0)
Tyrosine Kinase Inhibitors: Targeting Considerations (2003) (0)
Identification of oncogenic events in gastrointestinal stromal tumors (GISTs) by combined gene expression and copy number analysis. (2010) (0)
Accuracy of Endoscopic Ultrasound for Nodal Staging of Early Esophageal Cancer: 90 (2008) (0)
Copy Number in Melanoma Subtypes (2008) (0)
Subtypes Gene Mutations and Copy Number in Melanoma (2008) (0)
neurofibromatosis type 1 pathogenesis of gastrointestinal stromal tumours in Mitotic recombination as evidence of alternative (2007) (0)
Abstract 5673: Complex, patient-derived, multi-cell type, 3D models of breast cancer for personalized prediction of therapeutic response (2018) (0)
Abstract LB010: SMMART Program: A multi-omics tumor board with a focus on breast cancer (2021) (0)
383: Rare Expression or Mutation of C-KIT in Grade 4 Renal Cell Carcinoma with or without Sarcomatoid Differentiation (2006) (0)
Diagnostic algorithm for gastrointestinal stromal tumor (GIST) using patient registry data impacts pathology guidelines. (2020) (0)
Biclonal Desmoid-Type Fibromatosis With Two Beta-Catenin Mutations: Evidence for the Recruitment of Normal Myofibroblasts (2022) (0)
Dose-escalation study of a second-generation non-ansamycin HSP 90 inhibitor , onalespib ( AT 13387 ) , in combination with imatinib in patients with metastatic gastrointestinal stromal tumour * (0)
W1838 Development of Monoclonal Antibodies to Aid in the Diagnosis of Pancreatic Cancer (2008) (0)
ASO Visual Abstract: Ten-Year Survivorship in Patients with Metastatic Gastrointestinal Stromal Tumors (2022) (0)
DONOR POLYMORPHISM OF TUMOR NECROSIS FACTOR (TNF) GENES ASSOCIATED WITH VARIABLE SEVERITY OF HEPATITIS C (HCV) RECURRENCE FOLLOWING LIVER TRANSPLANTATION (1999) (0)
Imatinib-resistant gastrointestinal stromal tumors in the era of second- and third-line tyrosine kinase inhibitors: Does surgical resection have a role? (2021) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Christopher L. Corless?

Christopher L. Corless is affiliated with the following schools:

Christopher L. Corless's Academic­Influence.com Rankings

Christopher L. Corless's Degrees

Why Is Christopher L. Corless Influential?

Christopher L. Corless's Published Works

Published Works

What Schools Are Affiliated With Christopher L. Corless?

Christopher L. Corless's AcademicInfluence.com Rankings